• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.

作者信息

Doll M K, Nichols D E, Kilts J D, Prioleau C, Lawler C P, Lewis M M, Mailman R B

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907, USA.

出版信息

J Med Chem. 1999 Mar 11;42(5):935-40. doi: 10.1021/jm9804533.

DOI:10.1021/jm9804533
PMID:10072690
Abstract

In an analogy to the potent catechol dopamine D1 agonists dihydrexidine (1) and dinapsoline (2), benzo rings were fused onto the structures of the dopamine D2-selective agonists quinelorane (3) and quinpirole (4). Each of the phenyl ring-substituted derivatives had significant affinity for D2 receptors, albeit somewhat lower than the two parent compounds, 3 and 4. Compounds with N-propyl and N-allyl substituents (5b, 5c, 6c, and 6d) had higher affinity for the D2 dopamine receptor than did their corresponding secondary amines (5a and 6a). Slightly different effects on affinity of an n-propyl and an n-allyl group in the new analogues of 3 and 4 suggest that different binding orientations may be invoked at the receptor.

摘要

相似文献

1
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
J Med Chem. 1999 Mar 11;42(5):935-40. doi: 10.1021/jm9804533.
2
9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.9-二羟基-2,3,7,11b-四氢-1H-萘并[1,2,3-de]异喹啉:一种强效的多巴胺D1完全激动剂,含有刚性β-苯基多巴胺药效团。
J Med Chem. 1996 Jan 19;39(2):549-55. doi: 10.1021/jm950707+.
3
Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.作为D1和D2多巴胺受体配体的取代萘并[1,2,3 - de]异喹啉(二萘索林类似物)的合成与药理评价
Bioorg Med Chem. 2003 Apr 3;11(7):1451-64. doi: 10.1016/s0968-0896(02)00561-8.
4
Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.D1多巴胺受体药效基团的进一步定义:反式-6,6a,7,8,9,13b-六氢-5H-苯并[d]萘并[2,1-b]氮杂卓作为β-苯基多巴胺刚性类似物的合成。
J Med Chem. 1997 Jul 4;40(14):2140-7. doi: 10.1021/jm970157a.
5
Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.强效且高选择性D3受体配体的合成与药理学评价:对觅可卡因行为的抑制作用以及多巴胺D3/D2受体的作用
J Med Chem. 2003 Aug 28;46(18):3822-39. doi: 10.1021/jm0211220.
6
Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.地萘索林:帕金森病大鼠模型中一种D1多巴胺受体激动剂的特性研究
J Pharmacol Exp Ther. 2001 Feb;296(2):338-44.
7
8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.8,9 - 二羟基 - 1,2,3,11b - 四氢色烯并[4,3,2 - de]异喹啉(地诺昔林),对所有多巴胺受体亚型均为高亲和力且强效的激动剂。
Bioorg Med Chem. 2004 Mar 15;12(6):1403-12. doi: 10.1016/j.bmc.2004.01.008.
8
New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
J Med Chem. 2003 Jan 2;46(1):161-8. doi: 10.1021/jm021019a.
9
Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].多巴胺能前体药物的一种极具效力的口服活性苯并[g]喹啉类似物:1-丙基-反式-2,3,4,4a,5,7,8,9,10,10a-十氢-1H-苯并[g]喹啉-6-酮[已校正]
J Med Chem. 2006 Feb 23;49(4):1494-8. doi: 10.1021/jm051111h.
10
Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.多巴胺D1和D2激动剂对前脉冲抑制和运动的影响:Sprague-Dawley大鼠与瑞士 Webster、129X1/SvJ、C57BL/6J和DBA/2J小鼠的比较
J Pharmacol Exp Ther. 2005 Feb;312(2):733-41. doi: 10.1124/jpet.104.074468. Epub 2004 Oct 19.

引用本文的文献

1
Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule.神经保护抗帕金森氏症化合物 (-)-N6-(2-(4-(联苯-4-基)哌嗪-1-基)-乙基)-N6-丙基-4,5,6,7-四氢苯并[d]噻唑-2,6-二胺 (D-264) 的结构修饰:提高母体分子体内疗效的努力。
J Med Chem. 2014 Feb 27;57(4):1557-72. doi: 10.1021/jm401883v. Epub 2014 Feb 12.
2
Emerging therapies in the pharmacological treatment of Parkinson's disease.帕金森病药物治疗的新兴疗法
Drugs. 2002;62(5):775-86. doi: 10.2165/00003495-200262050-00005.